Drugs Made In America Acquisition II Corp. (DMII) Assets Average (2025 - 2026)

Drugs Made In America Acquisition (DMII) has reported Assets Average for 2 consecutive years, with $509.5 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Assets Average changed N/A year-over-year to $509.5 million in Q2 2026; TTM through Jun 2026 was $509.5 million, a N/A change from a year earlier, with the FY2025 full-year figure at $252.5 million, changed N/A from the prior year.
• Assets Average was $509.5 million for Q2 2026 at Drugs Made In America Acquisition, up from $503.0 million in the prior quarter.
• Over five years, Assets Average peaked at $509.5 million in Q2 2026 and troughed at $250.6 million in Q3 2025.